Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent

Twenty years since their first derivation, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown promise in disease modelling research, while their potential for cardiac repair is being investigated. However, low transfection efficiency is a barrier to wider realisation of the pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodbin, Sara E., Denning, Chris, Mosqueira, Diogo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564709/
https://www.ncbi.nlm.nih.gov/pubmed/32784848
http://dx.doi.org/10.3390/mps3030057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564709/
https://www.ncbi.nlm.nih.gov/pubmed/32784848
http://dx.doi.org/10.3390/mps3030057

Ejemplares similares